Transvaginal vs Transabdominal Ultrasound Guided Embryo Transfer (TVUSET)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Hadassah Medical Organization.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00826332
First received: January 21, 2009
Last updated: NA
Last verified: January 2009
History: No changes posted
  Purpose

Embryo transfer is the last step in the IVF process. it is now recognized that this step should be done carefully and that it affects success rates. in recent years, sonographic guidance appears to increase success rates.


Condition Intervention Phase
In Vitro Fertilization
Procedure: transabdominal ultrasound
Procedure: transvaginal ultrasound
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Transvaginal or Transabdominal Ultrasound Guided Embryo Transfer- Which is Better?

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • pregnancy [ Time Frame: 14 days ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • patient satisfaction [ Time Frame: 5 minutes ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 200
Study Start Date: January 2009
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Abdominal
Transabdominal ultrasound guided embryo transfer
Procedure: transabdominal ultrasound
transabdominal ultrasound
Active Comparator: Vaginal
Transvaginal ultrasound guided embryo transfer
Procedure: transvaginal ultrasound
transvaginal ultrasound

Detailed Description:

Embryo transfer is the last step in the IVF process. it involves the insertion of a soft catheter through the uterine cervix. It is now recognized that this step should be done carefully and that it affects success rates. The embyos should be carefully deposited in the cavity. special care should be given to avoid touching the uterine fundus during the procedure. In recent years, sonographic guidance appears to increase success rates.

  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • high quality embryos fro transfer

Exclusion Criteria:

  • repeated IVF failure
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00826332

Contacts
Contact: Ariel Revel, MD 97226776424 arielr2@hadassah.org.il
Contact: Hanna Bahuri 972504048587 hannab@hadassah.org.il

Locations
Israel
Hadassah University Hospital Recruiting
Jerusalem,, Israel, 91128
Contact: Ariel Revel, MD    97226776424    arielr2@hadassah.org.il   
Sponsors and Collaborators
Hadassah Medical Organization
  More Information

Publications:
Responsible Party: Ariel Revel, Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT00826332     History of Changes
Other Study ID Numbers: 0594-08-HMO-CTIL
Study First Received: January 21, 2009
Last Updated: January 21, 2009
Health Authority: Israel: Ministry of Health

Keywords provided by Hadassah Medical Organization:
ultrasound
IVF
Embryo transfer
Pregnancy rate
female patient undergoing IVF

ClinicalTrials.gov processed this record on September 18, 2014